Literature DB >> 10901294

Antiviral and virucidal activities against arenaviruses of zinc-finger active compounds.

C C García1, N A Candurra, E B Damonte.   

Abstract

Fifteen antiretroviral Zn-finger active compounds with diverse chemical structures, including azoic compounds, hydrazide derivatives, disulphide-based reagents and others were screened in vitro against Junin virus (JUNV), the aetiological agent of Argentine haemorrhagic fever, by a virus yield inhibition assay in Vero cells. Cytotoxicity was evaluated simultaneously by the MTT method. Of the compounds, three were totally inactive as antivirals, nine presented moderate anti JUNV-activity and three were truly active with EC50 (effective concentration 50%) values in the range 6.5-9.3 microM and with selectivity indices greater than 10. The most active inhibitors, named NSC20625, 3-7 and 2-71, demonstrated a broad range of action against arenaviruses, including several attenuated and pathogenic strains of JUNV as well as the antigenically related Tacaribe virus (TACV) and Pichinde virus (PICV). The direct treatment of JUNV and TACV virions with the compounds showed two types of behaviour: the aromatic disulphide NSC20625 was a very potent virucidal agent, whereas the other two compounds exhibited moderate or negligible virus-inactivating properties.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10901294     DOI: 10.1177/095632020001100306

Source DB:  PubMed          Journal:  Antivir Chem Chemother        ISSN: 0956-3202


  13 in total

Review 1.  Novel approaches in anti-arenaviral drug development.

Authors:  Andrew M Lee; Antonella Pasquato; Stefan Kunz
Journal:  Virology       Date:  2010-12-22       Impact factor: 3.616

2.  Elimination of retroviral infectivity by N-ethylmaleimide with preservation of functional envelope glycoproteins.

Authors:  David R Morcock; James A Thomas; Tracy D Gagliardi; Robert J Gorelick; J David Roser; Elena N Chertova; Julian W Bess; David E Ott; Quentin J Sattentau; Ines Frank; Melissa Pope; Jeffrey D Lifson; Louis E Henderson; Bruce J Crise
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

Review 3.  Drug discovery technologies and strategies for Machupo virus and other New World arenaviruses.

Authors:  Sheli R Radoshitzky; Jens H Kuhn; Fabian de Kok-Mercado; Peter B Jahrling; Sina Bavari
Journal:  Expert Opin Drug Discov       Date:  2012-05-19       Impact factor: 6.098

Review 4.  Progress in the experimental therapy of severe arenaviral infections.

Authors:  Brian B Gowen; Mike Bray
Journal:  Future Microbiol       Date:  2011-12       Impact factor: 3.165

5.  Arenavirus Z protein as an antiviral target: virus inactivation and protein oligomerization by zinc finger-reactive compounds.

Authors:  Cybele C García; Mahmoud Djavani; Ivan Topisirovic; Katherine L B Borden; María S Salvato; Elsa B Damonte
Journal:  J Gen Virol       Date:  2006-05       Impact factor: 3.891

6.  An antiviral disulfide compound blocks interaction between arenavirus Z protein and cellular promyelocytic leukemia protein.

Authors:  C C García; I Topisirovic; M Djavani; K L B Borden; E B Damonte; M S Salvato
Journal:  Biochem Biophys Res Commun       Date:  2010-02-10       Impact factor: 3.575

7.  A host-oriented inhibitor of Junin Argentine hemorrhagic fever virus egress.

Authors:  Jianhong Lu; Ziying Han; Yuliang Liu; Wenbo Liu; Michael S Lee; Mark A Olson; Gordon Ruthel; Bruce D Freedman; Ronald N Harty
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

Review 8.  Multifunctional nature of the arenavirus RING finger protein Z.

Authors:  Sarah Katharina Fehling; Frank Lennartz; Thomas Strecker
Journal:  Viruses       Date:  2012-11-09       Impact factor: 5.048

9.  Targeting of arenavirus RNA synthesis by a carboxamide-derivatized aromatic disulfide with virucidal activity.

Authors:  Claudia S Sepúlveda; Cybele C García; Jesica M Levingston Macleod; Nora López; Elsa B Damonte
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

Review 10.  Treatment of Argentine hemorrhagic fever.

Authors:  Delia A Enria; Ana M Briggiler; Zaida Sánchez
Journal:  Antiviral Res       Date:  2007-11-20       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.